Company intelligence / Profile preview

Diarect

Freiburg im Breisgau, Baden-Württemberg, Germany

Ownership: Private
Development stage: Other

Overview

Diarect develops and manufactures assay reagents—especially proteins and antigens—for immunodiagnostics; these are commercial products, not therapeutics. No clinical results are applicable as their products are for diagnostics rather than direct patient treatment[1][3].

Therapeutic areas: ImmunologyInfectious Diseases
Modalities: ProteinRecombinant proteinNative protein
Industry: Chemicals & Materials

Partnerships

Diagnostic and pharmaceutical companies (not individually specified)

Beyond the preview

Go deeper on Diarect.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diarect.

Explore the full profile